Which NSAID is typically preferred in the management of osteoarthritis due to its safety profile?

Meloxicam is typically preferred in the management of osteoarthritis largely due to its favorable safety profile, particularly in terms of gastrointestinal (GI) side effects. As a non-selective nonsteroidal anti-inflammatory drug (NSAID) with a longer half-life, meloxicam provides effective pain relief while allowing for once-daily dosing, which can enhance patient compliance.

Moreover, compared to other traditional NSAIDs, meloxicam has demonstrated a lower incidence of GI complications. This aspect is particularly important in older populations who are more susceptible to NSAID-associated gastric issues. While other options have their own benefits and risks, meloxicam is often favored because it balances effectiveness with a better safety margin, making it a suitable choice for long-term management of osteoarthritis.

In contrast, some NSAIDs may have a higher risk of cardiovascular events or gastrointestinal bleeding, which can make them less ideal for long-term use in certain populations. Thus, meloxicam's specific attributes make it a preferred option among healthcare providers when it comes to managing osteoarthritis pain while mitigating risks.